Delighted to announce that we have completed a successful pre-IND meeting with FDA on our oncology product SH105. The FDA’s prompt and definitive response confirms our clinical and regulatory strategy and aligns with our plan to accelerate the filling of our NDA. This positive outcome strengthens our efforts to bring SH105 to market benefiting women suffering […]
Shorla Pharma were delighted to recently attend ASCO’s annual meeting in Chicago and be present among healthcare professionals, patient advocates and scientists from around the world all of whom share the same goal: Improving the lives of patients with cancer.
Shorla were extremely honoured to accept the Network Ireland Tipperary, Businesswoman of the year award for Emerging New Business. Orlaith will go on to represent Shorla and Tipperary in the national finals in September. Congratulations to all the finalists and award winners.
Shorla are delighted to have been awarded a place on the MIT Harvard Medical School Healthcare Innovation Bootcamp in Cambridge MA June 2019. We are excited to participate in such a highly competitive programme, with a global community of innovators passionate about solving healthcare related problems and other innovation challenges.
Shorla were delighted to win best start up category in Ireland’s Best Young Entrepreneur competition 2019 for Tipperary. Sharon will go on to represent Shorla and Tipperary in the regional finals. Thank you to our fantastic Local Enterprise Office for their ongoing support, and to the wonderful mentors and judges for their expert advice and […]
Sharon and Orlaith were honoured to have the opportunity recently to meet Madam Speaker of the US House of Representatives Nancy Pelosi along with a congressional Delegation including the Chairman of the Ways and Means Committee Richard Neal. Madam Speaker Pelosi emphasised the strength of the business relationship between US and Ireland and complimented Sharon […]
We were delighted to recently attend the HBS Healthcare Conference. Relevant topics included healthcare finance and investing, drug pricing models and women’s healthcare. In addition key note speeches from industry pioneers and decision makers and excellent networking opportunities made this a very worthwhile trip. .